Cytogen 356

Known as: CYT 356, CYT-356 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
OBJECTIVES The sites of recurrent carcinoma of the prostate were localized with radiolabeled monoclonal antibody, and these sites… (More)
Is this relevant?
1997
1997
BACKGROUND Stored serum from clinical trial cases undergoing ProstaScint (CYT-356) scanning were available for Prostate Specific… (More)
Is this relevant?
1997
1997
BACKGROUND Prostate-specific membrane antigen (PSMA) is a transmembrane glycoprotein defined by the monoclonal antibody 7E11.C5… (More)
Is this relevant?
1996
1996
A Phase I dose-escalation study using 90Y-CYT-356 monoclonal antibody was performed in 12 patients with hormone-refractory… (More)
  • table 1
  • table 2
  • table 3
  • table 5
  • table 6
Is this relevant?
1996
1996
The utility of monoclonal antibody (MAb) imaging for detection of occult recurrent prostate cancer was investigated in 14… (More)
Is this relevant?
1995
1995
Prostate-specific membrane antigen (PSMA) is a trans-membrane glycoprotein recognized by the murine monoclonal antibody (MAb… (More)
Is this relevant?
1995
1995
The expression of the prostate-specific membrane antigen (PSMA) glycoprotein recognized by the murine monoclonal antibody (MAb… (More)
Is this relevant?
1994
1994
In an attempt to define the possible role of radioimmunoscintigraphy to assess noninvasively the pelvic lymph nodes, we studied… (More)
Is this relevant?
1994
1994
We assessed the safety and ability of the 111indium labeled immunoconjugate 7E11-C5.3-glycyl-tyrosyl-(N,e… (More)
Is this relevant?
1990
1990
In this study, a site-specific immunoconjugate, designated CYT-356, of the prostate-reactive monoclonal antibody 7E11-C5 was… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?